PRODUCT
Lumiracoxib |
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
|
||||||||||||||||||||||||
|
Description
Is a Cox-2 selective inhibitor NSAID. A member of the arylalkanoic acid family of NSAIDs it binds to a separate site than the other Cox-2 inhibitors. Concerns that it may cause liver failure prompted withdraw from the market.
See more information about other Cox 2 Inhibitors | ||||||||||||||||||||||||
| Specifications | ||||||||||||||||||||||||
|
||||||||||||||||||||||||



